2008
|
Sign up to set email alerts
Questioning Botulinum Toxin for Headache
Search citation statements
Order By: Relevance
Paper Sections
Select...
7
2
1
0
Citation Types
0
11
0
0
Year Published
Range
2008
20082019
2019Publication Types
Select...
8
1
Relationship
0
9
Authors
Journals
Cited by 9 publications
(11 citation statements)
References 16 publications
0
11
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Beyond BT's action on extracranial nociceptors, it remains arguable that BT “lacks a logical” or “reasonable” fundamental pathophysiologic mechanism for how it modulates pain . Numerous articles, in fact, have been published to provide a plausible explanation of the pain‐modulating properties of BTs.…”
Section: Discussion
mentioning
confidence: 99%
“…Beyond BT's action on extracranial nociceptors, it remains arguable that BT "lacks a logical" or "reasonable" fundamental pathophysiologic mechanism for how it modulates pain. 26,27 Numerous articles, in fact, have been published to provide a plausible explanation of the pain-modulating properties of BTs. Nociceptive transmission is dependent on specific neurotransmitters and is "well suited to inhibition by therapies affecting vesicular release of these."…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Beyond BT's action on extracranial nociceptors, it remains arguable that BT “lacks a logical” or “reasonable” fundamental pathophysiologic mechanism for how it modulates pain . Numerous articles, in fact, have been published to provide a plausible explanation of the pain‐modulating properties of BTs.…”
Section: Discussion
mentioning
confidence: 99%
“…Beyond BT's action on extracranial nociceptors, it remains arguable that BT "lacks a logical" or "reasonable" fundamental pathophysiologic mechanism for how it modulates pain. 26,27 Numerous articles, in fact, have been published to provide a plausible explanation of the pain-modulating properties of BTs. Nociceptive transmission is dependent on specific neurotransmitters and is "well suited to inhibition by therapies affecting vesicular release of these."…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Our study was not a double-blind trial, so the effect of botulinum toxin treatment may have been influenced by many biases. However, the effect of botulinum toxin A on nearby skin wrinkles makes it impossible to conduct a truly blinded study 15 . A high placebo response is an established confounder in evaluating the treatment of painful conditions 6 , 21 .…”
Section: Discussion
mentioning
confidence: 99%
“…The literature includes some placebo-controlled, double-blind trials conducted to evaluate the effectiveness of headache treatment with botulinum toxin A. Most authors conclude that botulinum toxin A is not highly effective, or not effective at all 2 , 15 . However, these trials mix headache types and/or injection sites and doses 3 , 4 , 6 , 7 , 23 .…”
Section: Discussion
mentioning
confidence: 99%
“…Furthermore, these studies do not mention the corrugator supercilii muscle as a specific site. Most importantly, there is no convincing rationale for this therapy 15 . Some authors do consider the effects of botulinum toxin A injection into the corrugator muscle and of resection of this muscle, but mainly for the treatment of migraine 16 , 17 , 18 , 20 , 24 , 25 …”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Beyond BT's action on extracranial nociceptors, it remains arguable that BT “lacks a logical” or “reasonable” fundamental pathophysiologic mechanism for how it modulates pain . Numerous articles, in fact, have been published to provide a plausible explanation of the pain‐modulating properties of BTs.…”
Section: Discussion
mentioning
confidence: 99%
“…Beyond BT's action on extracranial nociceptors, it remains arguable that BT "lacks a logical" or "reasonable" fundamental pathophysiologic mechanism for how it modulates pain. 26,27 Numerous articles, in fact, have been published to provide a plausible explanation of the pain-modulating properties of BTs. Nociceptive transmission is dependent on specific neurotransmitters and is "well suited to inhibition by therapies affecting vesicular release of these."…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Our study was not a double-blind trial, so the effect of botulinum toxin treatment may have been influenced by many biases. However, the effect of botulinum toxin A on nearby skin wrinkles makes it impossible to conduct a truly blinded study 15 . A high placebo response is an established confounder in evaluating the treatment of painful conditions 6 , 21 .…”
Section: Discussion
mentioning
confidence: 99%
“…The literature includes some placebo-controlled, double-blind trials conducted to evaluate the effectiveness of headache treatment with botulinum toxin A. Most authors conclude that botulinum toxin A is not highly effective, or not effective at all 2 , 15 . However, these trials mix headache types and/or injection sites and doses 3 , 4 , 6 , 7 , 23 .…”
Section: Discussion
mentioning
confidence: 99%
“…Furthermore, these studies do not mention the corrugator supercilii muscle as a specific site. Most importantly, there is no convincing rationale for this therapy 15 . Some authors do consider the effects of botulinum toxin A injection into the corrugator muscle and of resection of this muscle, but mainly for the treatment of migraine 16 , 17 , 18 , 20 , 24 , 25 …”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Beyond BT's action on extracranial nociceptors, it remains arguable that BT “lacks a logical” or “reasonable” fundamental pathophysiologic mechanism for how it modulates pain . Numerous articles, in fact, have been published to provide a plausible explanation of the pain‐modulating properties of BTs.…”
Section: Discussion
mentioning
confidence: 99%
“…Beyond BT's action on extracranial nociceptors, it remains arguable that BT "lacks a logical" or "reasonable" fundamental pathophysiologic mechanism for how it modulates pain. 26,27 Numerous articles, in fact, have been published to provide a plausible explanation of the pain-modulating properties of BTs. Nociceptive transmission is dependent on specific neurotransmitters and is "well suited to inhibition by therapies affecting vesicular release of these."…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Our study was not a double-blind trial, so the effect of botulinum toxin treatment may have been influenced by many biases. However, the effect of botulinum toxin A on nearby skin wrinkles makes it impossible to conduct a truly blinded study 15 . A high placebo response is an established confounder in evaluating the treatment of painful conditions 6 , 21 .…”
Section: Discussion
mentioning
confidence: 99%
“…The literature includes some placebo-controlled, double-blind trials conducted to evaluate the effectiveness of headache treatment with botulinum toxin A. Most authors conclude that botulinum toxin A is not highly effective, or not effective at all 2 , 15 . However, these trials mix headache types and/or injection sites and doses 3 , 4 , 6 , 7 , 23 .…”
Section: Discussion
mentioning
confidence: 99%
“…Furthermore, these studies do not mention the corrugator supercilii muscle as a specific site. Most importantly, there is no convincing rationale for this therapy 15 . Some authors do consider the effects of botulinum toxin A injection into the corrugator muscle and of resection of this muscle, but mainly for the treatment of migraine 16 , 17 , 18 , 20 , 24 , 25 …”
Section: Discussion
mentioning
confidence: 99%